BVT

Bionic Vision Technologies has developed the BVT Bionic Eye System, the world's first suprachoroidal visual implant designed to restore functional vision in blind individuals with inherited retinal diseases. The company recently completed an initial human trial involving seven patients, demonstrating safety and efficacy in terms of patient mobility and device stability/durability, with positive outcomes achieved. We plan to initiate global clinical trials in key markets including Australia, the United States, and Europe, with commercialization expected to follow shortly thereafter.